Published in Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz on May 01, 2004
Comparative population dynamics of a generalist (Ixodes ricinus) and specialist tick (I. hexagonus) species from European hedgehogs. Exp Appl Acarol (2011) 0.99
Dynamics of distribution and efficacy of different spot-on permethrin formulations in dogs artificially infested with Dermacentor reticulatus. Parasit Vectors (2011) 0.96
Tick infestation risk and Borrelia burgdorferi s.l. infection-induced increase in host-finding efficacy of female Ixodes ricinus under natural conditions. Exp Appl Acarol (2008) 0.85
Three years of bluetongue disease in central Europe with special reference to Germany: what lessons can be learned? Wien Klin Wochenschr (2010) 0.78
Immunochemical and immunological analysis of European Borrelia burgdorferi strains. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 5.06
The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun (1993) 3.50
Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22 kDa protein (pC) in Escherichia coli. Mol Microbiol (1992) 3.45
Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection. Infection (1993) 2.89
Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development. Proc Natl Acad Sci U S A (1993) 2.77
The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful. Clin Microbiol Infect (2014) 2.62
Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect (2004) 2.59
European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 2.43
EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol (2009) 2.31
Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect (2011) 2.23
Lyme borreliosis: basic science and clinical aspects. Lancet (1994) 2.19
Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture. J Clin Microbiol (1999) 2.14
The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology (2005) 2.13
Comparative analysis of the Borrelia garinii genome. Nucleic Acids Res (2004) 1.96
Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi. Med Microbiol Immunol (1993) 1.89
Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. Infect Immun (1997) 1.79
Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol (1996) 1.70
Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorferi sensu lato: relationship to ospA genotype and evidence of lateral gene exchange of ospC. J Clin Microbiol (1995) 1.67
Repeated isolation of spirochetes from the cerebrospinal fluid of a patient with meningoradiculitis Bannwarth. Eur J Clin Microbiol (1984) 1.64
Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection (1990) 1.61
Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus. J Clin Microbiol (1995) 1.60
Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato. Med Microbiol Immunol (1994) 1.56
Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology (2002) 1.53
Lyme disease presenting as Tourette's syndrome. Lancet (1998) 1.50
Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature. J Clin Microbiol (1999) 1.49
Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol (1997) 1.45
Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis (1986) 1.45
Serological diagnosis of erythema migrans disease and related disorders. Infection (1985) 1.42
Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J Clin Microbiol (1997) 1.40
Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment. Minerva Med (2009) 1.38
Cross-reactive proteins of Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis (1992) 1.36
In vitro and in vivo susceptibility of Borrelia burgdorferi. Eur J Clin Microbiol (1987) 1.36
The spirochetal etiology of lymphocytic meningoradiculitis of Bannwarth (Bannwarth's syndrome). J Neurol (1984) 1.34
Clinical evaluation of a recombinant hepatitis B vaccine. Lancet (1984) 1.33
An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types. Med Microbiol Immunol (2003) 1.33
Antigenic heterogeneity of European Borrelia burgdorferi strains isolated from patients and ticks. Lancet (1985) 1.33
First confirmed autochthonous case of human Babesia microti infection in Europe. Eur J Clin Microbiol Infect Dis (2007) 1.33
Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi. Med Microbiol Immunol (1992) 1.32
Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species. Med Microbiol Immunol (1995) 1.32
Molecular diagnosis of sepsis: New aspects and recent developments. Eur J Microbiol Immunol (Bp) (2014) 1.30
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm (Vienna) (2004) 1.26
Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol (1999) 1.26
Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Med Microbiol Immunol (1993) 1.25
Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection (1996) 1.24
Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis (1989) 1.24
Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR. J Clin Microbiol (1996) 1.19
Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis. J Clin Microbiol (1997) 1.18
Apodemus species mice are reservoir hosts of Borrelia garinii OspA serotype 4 in Switzerland. J Clin Microbiol (2002) 1.17
A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis. J Clin Microbiol (2000) 1.17
Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J Infect Dis (1991) 1.15
Transmission of Borrelia garinii OspA serotype 4 to BALB/c mice by Ixodes ricinus ticks collected in the field. J Clin Microbiol (2001) 1.15
Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease. Infection (1991) 1.13
Molecular polymorphism of the lyme disease agent Borrelia garinii in northern Europe is influenced by a novel enzootic Borrelia focus in the North Atlantic. J Clin Microbiol (1996) 1.12
European erythema migrans disease and related disorders. Yale J Biol Med (1985) 1.11
Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe. Clin Diagn Lab Immunol (1998) 1.11
Reinfection with Borrelia burgdorferi. Lancet (1986) 1.10
Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans. Med Microbiol Immunol (1998) 1.10
Genetic analysis of Borrelia garinii OspA serotype 4 strains associated with neuroborreliosis: evidence for extensive genetic homogeneity. J Clin Microbiol (1999) 1.10
Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis. Clin Dev Immunol (2011) 1.08
Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA-type-specific PCR in synovial fluid from patients with Lyme arthritis. Med Microbiol Immunol (1998) 1.06
Culture of Borrelia burgdorferi on six solid media. Eur J Clin Microbiol Infect Dis (1991) 1.06
[Clinical aspects and etiology of acrodermatitis chronica atrophicans]. Hautarzt (1984) 1.06
Host cell-specific expression of a p44 epitope by the human granulocytic ehrlichiosis agent. J Infect Dis (2001) 1.05
Coexistence of ehrlichiae of the phagocytophila group with Borrelia burgdorferi in Ixodes ricinus from Southern Germany. Med Microbiol Immunol (1999) 1.05
Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant. J Med Microbiol (2000) 1.02
Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. J Clin Microbiol (1998) 1.01
Myositis caused by Borrelia burgdorferi: report of four cases. J Neurol Sci (1989) 1.01
Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs. Neurology (1989) 1.01
Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection (1996) 1.00
Comparison of OspA serotypes for Borrelia burgdorferi sensu lato from Japan, Europe and North America. Microbiol Immunol (1996) 1.00
Long-term in vitro cultivation of Borrelia burgdorferi sensu lato strains: influence on plasmid patterns, genome stability and expression of proteins. Res Microbiol (1997) 0.99
Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain (2001) 0.99
Borrelia burgdorferi sensu lato strains isolated from cutaneous Lyme borreliosis biopsies differentiated by pulsed-field gel electrophoresis. Scand J Infect Dis (1996) 0.97
Differential expression of outer surface proteins A and C by individual Borrelia burgdorferi in different genospecies. Med Microbiol Immunol (2000) 0.97
Taxonomic classification of 29 Borrelia burgdorferi strains isolated from patients with Lyme borreliosis: a comparison of five different phenotypic and genotypic typing schemes. Med Microbiol Immunol (1994) 0.97
Prevalence of four species of Borrelia burgdorferi sensu lato and coinfection with Anaplasma phagocytophila in Ixodes ricinus ticks in central Germany. Eur J Clin Microbiol Infect Dis (2003) 0.97
Osp17, a novel immunodominant outer surface protein of Borrelia afzelii: recombinant expression in Escherichia coli and its use as a diagnostic antigen for serodiagnosis of Lyme borreliosis. Med Microbiol Immunol (1999) 0.96
Human babesiosis in Europe: what clinicians need to know. Infection (2013) 0.96
An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis. Med Microbiol Immunol (1999) 0.95
Evidence of lymphangiogenesis in Warthin's tumor of the parotid gland. Oral Oncol (2006) 0.95
Detection of Mycoplasma pneumoniae DNA in cerebrospinal fluid of a patient with M. pneumoniae infection-"associated" stroke. Clin Infect Dis (2001) 0.95
Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Arch Neurol (1989) 0.94
Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection (1994) 0.93
High prevalence of genetically diverse Borrelia bavariensis-like strains in Ixodes persulcatus from Selenge Aimag, Mongolia. Ticks Tick Borne Dis (2012) 0.93
Phagocytosis of microorganisms by means of overshooting pseudopods: where do we stand? Microbes Infect (1999) 0.92
[Lyme borreliosis in South Germany. Epidemiologic data on the incidence of cases and on the epidemiology of ticks (Ixodes ricinus) carrying Borrelia burgdorferi]. Dtsch Med Wochenschr (1987) 0.92
Enzyme-linked immunosorbent assays with recombinant internal flagellin fragments derived from different species of Borrelia burgdorferi sensu lato for the serodiagnosis of Lyme neuroborreliosis. Med Microbiol Immunol (1997) 0.92
Increased anti-streptococcal antibodies in patients with Tourette's syndrome. Psychiatry Res (2000) 0.91